Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.

Abstract

To investigate thrombin activatable fibrinolysis inhibitor (TAFI) in ischemic stroke and its relationship to fibrinolysis and inflammation, we investigated 32 patients with ischemic stroke during the acute phase and after 60 days. TAFI antigen levels, global markers of hemostasis (coagulation and fibrinolysis) and inflammatory markers were measured in… (More)

Topics

Cite this paper

@article{Rooth2007ThrombinAF, title={Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.}, author={Elisabeth Rooth and H{\aa}kan N. Wall{\'e}n and Alexandra Antovic and Magnus H von Arbin and Georgios Kaponides and Nils Wahlgren and Margareta Blomb{\"a}ck and Joven Antovic}, journal={Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis}, year={2007}, volume={18 4}, pages={365-70} }